NRX Pharmaceuticals
NRXP · NASDAQ
$2.62−$0.01 (−0.38%)TodayMarket closed ·
Prev close $2.63
Who owns NRXP
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 31.9% of NRXP’s shares.
- B Group, Inc.11.3%
- Vanguard Capital Management, LLC4.5%
- Javitt (Jonathan C)4.2%
- Columbia Threadneedle Investments (US)2.6%
- Next 6 largest institutions9.4%
- All other shareholders68.1%
| Holder | Shares | % of shares |
|---|---|---|
| B Group, Inc. | 4.09M | 11.29% |
| Vanguard Capital Management, LLC | 1.62M | 4.47% |
| Javitt (Jonathan C) | 1.52M | 4.19% |
| Columbia Threadneedle Investments (US) | 928.73K | 2.56% |
| Balyasny Asset Management LP | 893.86K | 2.47% |
| Citadel Advisors LLC | 680.04K | 1.88% |
| AdvisorShares Investments, LLC | 659.02K | 1.82% |
| Commonwealth Financial Network | 454.42K | 1.25% |
| UBS Financial Services, Inc. | 402.54K | 1.11% |
| Geode Capital Management, L.L.C. | 314.66K | 0.87% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.27M | 3.50% |
| AdvisorShares Psychedelics ETF | 750.02K | 2.07% |
| Vanguard Extended Market Index Fund | 313.88K | 0.87% |
| Fidelity Extended Market Index Fund | 144.66K | 0.40% |
| iShares Micro-Cap ETF | 106.35K | 0.29% |
Short interest
Settled Sep 30, 2026
- Shares short
- 9.79M
- Days to cover
- 13.98
- % of shares outstanding
- 27.03%
- Average daily volume
- 700.44K
- Change since last report
- +0.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.